Datamonitor - Pharmaceuticals and Healthcare

Forecast Insight: Dyslipidemia - Genericization and negative trial data drive market shrinking
Analysis of the competitive landscape and the recent changes in antidyslipidemics across seven major markets. Explores the key events that are likely to impact the performance of the antidyslipidemics, and provides sales forecasts to 2017.

Published 27 August 2008 - Report

Commercial Insight: Select herpes viruses and human papilloma virus - Non-biologic interventions for oral and genital herpes, cytomegalovirus infection, herpes zoster and genital warts
Analysis of the commercial landscape for pharmacological therapies for the major Herpes-family viruses as well as an assessment of non-vaccine human papilloma virus treatments, including 2007 IMS sales data and 10 year sales forecast for the 7 MM

Published 26 August 2008 - Report

Diabetes Market Forecast
Analysis of the competitive landscape and the recent changes in antidiabetics across seven major markets. Analysis of the threats to currently marketed drugs. Assessment of the opportunities available to novel agents classes.

Published 26 August 2008 - Interactive Model

Forecast Insight: Antidiabetics - Switching to new molecule antidiabetics drives market growth
Competitive landscape analysis with threats to currently marketed drugs and recent changes in antidiabetics across seven major markets. Assessment of the opportunities available to novel agent classes, including DPP-IV inhibitors and GLP-1 agonists.

Published 26 August 2008 - Report

Antihormonal Therapy Cancer Brand Forecasts
Overview and analysis of the antihormonal therapy cancer brands in each of the seven major markets based on 2007 sales. Includes forecasts to 2017 in light of key events set to influence product sales.

Published 21 August 2008 - Interactive Model

Big Pharma M&A Analysis to 2012 - Surveying the growth rate landscape

Published 21 August 2008 - Report

Commercial Insight: Antihormonal Therapy Cancer Brands - Careful lifecycle management needed to preserve brand dominance

Published 21 August 2008 - Report

Commercial Insight: Top 20 Therapy Cancer Brands - Key brands set to consolidate advantage as competition intensifies

Published 21 August 2008 - Report

Top 20 Therapy Cancer Brand Forecasts

Published 21 August 2008 - Interactive Model

Commercial Insight: HIV - The battle for market share is getting fiercer

Published 20 August 2008 - Report

Forecast Insight: Insomnia - Orexin and serotonin receptor modulators to innovate market